Frontier Wealth Management’s Gilead Sciences GILD Stock Holding History

Frontier Wealth Management’s Portfolio GILD Stock Details GILD Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2022 Q2	$1.55M	Buy	25,099 +1,852	+8%	+$115K	0.11%	143
2022 Q1	$1.43M	Sell	23,247 -737	-3%	-$47.1K	0.02%	149
2021 Q4	$1.74M	Sell	23,984 -1,038	-4%	-$71.5K	0.11%	133
2021 Q3	$1.75M	Sell	25,022 -569	-2%	-$40K	0.12%	128
2021 Q2	$1.76M	Sell	25,591 -1,267	-5%	-$84.6K	0.12%	129
2021 Q1	$1.74M	Sell	26,858 -439	-2%	-$28.3K	0.13%	123
2020 Q4	$1.59M	Sell	27,297 -1,158	-4%	-$69.9K	0.13%	126
2020 Q3	$1.8M	Sell	28,455 -5,321	-16%	-$369K	0.16%	103
2020 Q2	$2.6M	Sell	33,776 -6	-0%	-$460	0.24%	83
2020 Q1	$2.53M	Buy	33,782 +3,106	+10%	+$215K	0.41%	68
2019 Q4	$1.99M	Sell	30,676 -10,124	-25%	-$659K	0.32%	72
2019 Q3	$2.59M	Sell	40,800 -15,842	-28%	-$1.04M	0.38%	56
2019 Q2	$3.83M	Sell	56,642 -5,237	-8%	-$345K	0.56%	41
2019 Q1	$4.02M	Sell	61,879 -4,244	-6%	-$282K	0.55%	41
2018 Q4	$4.14M	Buy	66,123 +2,193	+3%	+$153K	0.63%	37
2018 Q3	$4.94M	Sell	63,930 -23,753	-27%	-$1.79M	0.47%	28
2018 Q2	$6.21M	Sell	87,683 -12,473	-12%	-$881K	0.89%	18
2018 Q1	$7.55M	Sell	100,156 -2,611	-3%	-$208K	1.06%	17
2017 Q4	$7.36M	Sell	102,767 -15,120	-13%	-$1.15M	1.18%	17
2017 Q3	$9.55M	Sell	117,887 -15,744	-12%	-$1.2M	1.38%	13
2017 Q2	$9.46M	Buy	133,631 +12,870	+11%	+$856K	1.45%	12
2017 Q1	$8.2M	Sell	120,761 -7,121	-6%	-$501K	1.26%	13
2016 Q4	$9.16M	Buy	127,882 +15,359	+14%	+$1.14M	1.5%	10
2016 Q3	$8.9M	Sell	112,523 -1,794	-2%	-$146K	1.35%	10
2016 Q2	$9.54M	Buy	114,317 +3,203	+3%	+$284K	1.53%	10
2016 Q1	$10.2M	Sell	111,114 -1,173	-1%	-$106K	0.85%	11
2015 Q4	$11.4M	Buy	112,287 +952	+0.9%	+$99.1K	1.82%	9
2015 Q3	$10.9M	Buy	111,335 +29,490	+36%	+$3.28M	1.73%	9
2015 Q2	$9.58M	Buy	81,845 +77,053	+1,608%	+$8.42M	1.47%	11
2015 Q1	$470K	Buy	4,792 +1,301	+37%	+$132K	0.08%	176
2014 Q4	$329K	Buy	+3,491	New	+$361K	0.06%	178

Other funds holding GILD

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Capital Research Global Investors Los Angeles, California $717B AUM 35.42% 1-Year Est. Return

Capital World Investors Los Angeles, California $846B AUM 46.74% 1-Year Est. Return

Dodge & Cox San Francisco, California $191B AUM 17.5% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

Arrowstreet Capital Boston, Massachusetts $225B AUM 49.49% 1-Year Est. Return

Northern Trust Chicago, Illinois $860B AUM 41.15% 1-Year Est. Return

Frontier Wealth Management's GILD Position: Q2 2022 in Review

Frontier Wealth Management increased its Gilead Sciences (GILD) stake by 8% in Q2 2022, buying an estimated $115K and bringing the position to 25,099 shares worth $1.55M. The position accounts for 0.11% of the portfolio, ranked #143.

Frontier Wealth Management first reported a position in GILD in Q4 2014 and has held it in 31 quarters since. The position peaked at $11.4M in Q4 2015. 1,604 funds tracked by Wall St. Rank hold GILD as of Q2 2022.

Frontier Wealth Management held 25,099 shares of Gilead Sciences worth $1.55M as of Q2 2022.
Frontier Wealth Management bought 1,852 Gilead Sciences shares in Q2 2022, an estimated $115K.
Gilead Sciences made up 0.11% of Frontier Wealth Management's portfolio in Q2 2022, its #143 holding.
Frontier Wealth Management first reported a position in Gilead Sciences in Q4 2014 and has held it in 31 quarters since.
Frontier Wealth Management's Gilead Sciences position peaked at $11.4M in Q4 2015.
1,604 funds tracked by Wall St. Rank held Gilead Sciences as of Q2 2022.

Based on Frontier Wealth Management's 13F filing for Q2 2022, filed 12 Aug 2022.